CONMED Corporation (CNMD): Price and Financial Metrics
CONMED Corporation (CNMD)
Today's Latest Price: $103.32 USD
Updated Nov 23 6:40pm
Add CNMD to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
CNMD Stock Summary
- CNMD's went public 30.68 years ago, making it older than 84.52% of listed US stocks we're tracking.
- With a price/earnings ratio of 9,309.77, Conmed Corp P/E ratio is greater than that of about 99.83% of stocks in our set with positive earnings.
- Price to trailing twelve month operating cash flow for CNMD is currently 33.96, higher than 87.9% of US stocks with positive operating cash flow.
- If you're looking for stocks that are quantitatively similar to Conmed Corp, a group of peers worth examining would be POST, VCEL, WPRT, HPE, and QADB.
- CNMD's SEC filings can be seen here. And to visit Conmed Corp's official web site, go to www.conmed.com.
CNMD Stock Price Chart Interactive Chart >
CNMD Price/Volume Stats
| Current price | $103.32 | 52-week high | $116.81 |
| Prev. close | $101.23 | 52-week low | $37.66 |
| Day low | $102.36 | Volume | 320,200 |
| Day high | $104.48 | Avg. volume | 363,324 |
| 50-day MA | $84.57 | Dividend yield | 0.77% |
| 200-day MA | $78.51 | Market Cap | 2.96B |
CONMED Corporation (CNMD) Company Bio
CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company was founded in 1970 and is based in Utica, New York.
CNMD Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $103.32 | $23.78 | -77% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Conmed Corp. To summarize, we found that Conmed Corp ranked in the 18th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 76.5%. In terms of the factors that were most noteworthy in this DCF analysis for CNMD, they are:
- Conmed Corp's weighted average cost of capital (WACC) is 9%; for context, that number is higher than 66.29% of tickers in our DCF set.
- CNMD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 10%; for context, that number is higher than 66.29% of tickers in our DCF set.
- Relative to other stocks in its sector (Healthcare), Conmed Corp has a reliance on debt greater than 62.91% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -77% |
| 1% | -77% |
| 2% | -77% |
| 3% | -76% |
| 4% | -76% |
| 5% | -76% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CNMD, try LMNX, CNC, MOH, NUVA, and GMED.
Loading social stream, please wait...